
Global Sacubitril Valsartan Sodium Drugs Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Sacubitril Valsartan Sodium Drugs market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Sacubitril Valsartan Sodium Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Sacubitril Valsartan Sodium Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Sacubitril Valsartan Sodium Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Sacubitril Valsartan Sodium Drugs include Addii Biotech, Arlak Corazon, Cipla, Farmanova pharma, General Pharmaceuticals, MSN, Novartis, Sanof and Changzhou Pharmaceutical Factory, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sacubitril Valsartan Sodium Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sacubitril Valsartan Sodium Drugs.
The Sacubitril Valsartan Sodium Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sacubitril Valsartan Sodium Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Sacubitril Valsartan Sodium Drugs Segment by Company
Addii Biotech
Arlak Corazon
Cipla
Farmanova pharma
General Pharmaceuticals
MSN
Novartis
Sanof
Changzhou Pharmaceutical Factory
Chengdu Brilliant Pharmaceutical
TC Pharmaceuticals (Jiangsu)
Sino Therapeutics
Kelun Pharmaceutical
Qilu Pharmaceutical
Shenzhen Salubris Pharmaceuticals
CSPC Ouyi Pharmaceutical
Sihuan Pharmaceutical
Zhejiang AngLiKang Pharmaceutical
Zhejiang Nord Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Sacubitril Valsartan Sodium Drugs Segment by Type
Tablets
Oral Pellets
Sacubitril Valsartan Sodium Drugs Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Sacubitril Valsartan Sodium Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sacubitril Valsartan Sodium Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sacubitril Valsartan Sodium Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sacubitril Valsartan Sodium Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sacubitril Valsartan Sodium Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Sacubitril Valsartan Sodium Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Sacubitril Valsartan Sodium Drugs market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Sacubitril Valsartan Sodium Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Sacubitril Valsartan Sodium Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Sacubitril Valsartan Sodium Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Sacubitril Valsartan Sodium Drugs include Addii Biotech, Arlak Corazon, Cipla, Farmanova pharma, General Pharmaceuticals, MSN, Novartis, Sanof and Changzhou Pharmaceutical Factory, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sacubitril Valsartan Sodium Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sacubitril Valsartan Sodium Drugs.
The Sacubitril Valsartan Sodium Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sacubitril Valsartan Sodium Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Sacubitril Valsartan Sodium Drugs Segment by Company
Addii Biotech
Arlak Corazon
Cipla
Farmanova pharma
General Pharmaceuticals
MSN
Novartis
Sanof
Changzhou Pharmaceutical Factory
Chengdu Brilliant Pharmaceutical
TC Pharmaceuticals (Jiangsu)
Sino Therapeutics
Kelun Pharmaceutical
Qilu Pharmaceutical
Shenzhen Salubris Pharmaceuticals
CSPC Ouyi Pharmaceutical
Sihuan Pharmaceutical
Zhejiang AngLiKang Pharmaceutical
Zhejiang Nord Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Sacubitril Valsartan Sodium Drugs Segment by Type
Tablets
Oral Pellets
Sacubitril Valsartan Sodium Drugs Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Sacubitril Valsartan Sodium Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sacubitril Valsartan Sodium Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sacubitril Valsartan Sodium Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sacubitril Valsartan Sodium Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sacubitril Valsartan Sodium Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Sacubitril Valsartan Sodium Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
127 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Sacubitril Valsartan Sodium Drugs Market Size Estimates and Forecasts (2020-2031)
- 1.2.2 Global Sacubitril Valsartan Sodium Drugs Sales Estimates and Forecasts (2020-2031)
- 1.3 Sacubitril Valsartan Sodium Drugs Market by Type
- 1.3.1 Tablets
- 1.3.2 Oral Pellets
- 1.4 Global Sacubitril Valsartan Sodium Drugs Market Size by Type
- 1.4.1 Global Sacubitril Valsartan Sodium Drugs Market Size Overview by Type (2020-2031)
- 1.4.2 Global Sacubitril Valsartan Sodium Drugs Historic Market Size Review by Type (2020-2025)
- 1.4.3 Global Sacubitril Valsartan Sodium Drugs Forecasted Market Size by Type (2026-2031)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Sacubitril Valsartan Sodium Drugs Sales Breakdown by Type (2020-2025)
- 1.5.2 Europe Sacubitril Valsartan Sodium Drugs Sales Breakdown by Type (2020-2025)
- 1.5.3 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Breakdown by Type (2020-2025)
- 1.5.4 South America Sacubitril Valsartan Sodium Drugs Sales Breakdown by Type (2020-2025)
- 1.5.5 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Breakdown by Type (2020-2025)
- 2 Global Market Dynamics
- 2.1 Sacubitril Valsartan Sodium Drugs Industry Trends
- 2.2 Sacubitril Valsartan Sodium Drugs Industry Drivers
- 2.3 Sacubitril Valsartan Sodium Drugs Industry Opportunities and Challenges
- 2.4 Sacubitril Valsartan Sodium Drugs Industry Restraints
- 3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Sacubitril Valsartan Sodium Drugs Revenue (2020-2025)
- 3.2 Global Top Players by Sacubitril Valsartan Sodium Drugs Sales (2020-2025)
- 3.3 Global Top Players by Sacubitril Valsartan Sodium Drugs Price (2020-2025)
- 3.4 Global Sacubitril Valsartan Sodium Drugs Industry Company Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Sacubitril Valsartan Sodium Drugs Major Company Production Sites & Headquarters
- 3.6 Global Sacubitril Valsartan Sodium Drugs Company, Product Type & Application
- 3.7 Global Sacubitril Valsartan Sodium Drugs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sacubitril Valsartan Sodium Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sacubitril Valsartan Sodium Drugs Players Market Share by Revenue in 2024
- 3.8.3 2023 Sacubitril Valsartan Sodium Drugs Tier 1, Tier 2, and Tier 3
- 4 Sacubitril Valsartan Sodium Drugs Regional Status and Outlook
- 4.1 Global Sacubitril Valsartan Sodium Drugs Market Size and CAGR by Region: 2020 VS 2024 VS 2031
- 4.2 Global Sacubitril Valsartan Sodium Drugs Historic Market Size by Region
- 4.2.1 Global Sacubitril Valsartan Sodium Drugs Sales in Volume by Region (2020-2025)
- 4.2.2 Global Sacubitril Valsartan Sodium Drugs Sales in Value by Region (2020-2025)
- 4.2.3 Global Sacubitril Valsartan Sodium Drugs Sales (Volume & Value), Price and Gross Margin (2020-2025)
- 4.3 Global Sacubitril Valsartan Sodium Drugs Forecasted Market Size by Region
- 4.3.1 Global Sacubitril Valsartan Sodium Drugs Sales in Volume by Region (2026-2031)
- 4.3.2 Global Sacubitril Valsartan Sodium Drugs Sales in Value by Region (2026-2031)
- 4.3.3 Global Sacubitril Valsartan Sodium Drugs Sales (Volume & Value), Price and Gross Margin (2026-2031)
- 5 Sacubitril Valsartan Sodium Drugs by Application
- 5.1 Sacubitril Valsartan Sodium Drugs Market by Application
- 5.1.1 Hospital and Clinic
- 5.1.2 Retail Pharmacies
- 5.1.3 Other
- 5.2 Global Sacubitril Valsartan Sodium Drugs Market Size by Application
- 5.2.1 Global Sacubitril Valsartan Sodium Drugs Market Size Overview by Application (2020-2031)
- 5.2.2 Global Sacubitril Valsartan Sodium Drugs Historic Market Size Review by Application (2020-2025)
- 5.2.3 Global Sacubitril Valsartan Sodium Drugs Forecasted Market Size by Application (2026-2031)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Sacubitril Valsartan Sodium Drugs Sales Breakdown by Application (2020-2025)
- 5.3.2 Europe Sacubitril Valsartan Sodium Drugs Sales Breakdown by Application (2020-2025)
- 5.3.3 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Breakdown by Application (2020-2025)
- 5.3.4 South America Sacubitril Valsartan Sodium Drugs Sales Breakdown by Application (2020-2025)
- 5.3.5 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Breakdown by Application (2020-2025)
- 6 Company Profiles
- 6.1 Addii Biotech
- 6.1.1 Addii Biotech Comapny Information
- 6.1.2 Addii Biotech Business Overview
- 6.1.3 Addii Biotech Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 Addii Biotech Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.1.5 Addii Biotech Recent Developments
- 6.2 Arlak Corazon
- 6.2.1 Arlak Corazon Comapny Information
- 6.2.2 Arlak Corazon Business Overview
- 6.2.3 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 Arlak Corazon Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.2.5 Arlak Corazon Recent Developments
- 6.3 Cipla
- 6.3.1 Cipla Comapny Information
- 6.3.2 Cipla Business Overview
- 6.3.3 Cipla Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 Cipla Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.3.5 Cipla Recent Developments
- 6.4 Farmanova pharma
- 6.4.1 Farmanova pharma Comapny Information
- 6.4.2 Farmanova pharma Business Overview
- 6.4.3 Farmanova pharma Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 Farmanova pharma Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.4.5 Farmanova pharma Recent Developments
- 6.5 General Pharmaceuticals
- 6.5.1 General Pharmaceuticals Comapny Information
- 6.5.2 General Pharmaceuticals Business Overview
- 6.5.3 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.5.5 General Pharmaceuticals Recent Developments
- 6.6 MSN
- 6.6.1 MSN Comapny Information
- 6.6.2 MSN Business Overview
- 6.6.3 MSN Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 MSN Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.6.5 MSN Recent Developments
- 6.7 Novartis
- 6.7.1 Novartis Comapny Information
- 6.7.2 Novartis Business Overview
- 6.7.3 Novartis Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.7.4 Novartis Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.7.5 Novartis Recent Developments
- 6.8 Sanof
- 6.8.1 Sanof Comapny Information
- 6.8.2 Sanof Business Overview
- 6.8.3 Sanof Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.8.4 Sanof Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.8.5 Sanof Recent Developments
- 6.9 Changzhou Pharmaceutical Factory
- 6.9.1 Changzhou Pharmaceutical Factory Comapny Information
- 6.9.2 Changzhou Pharmaceutical Factory Business Overview
- 6.9.3 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.9.4 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.9.5 Changzhou Pharmaceutical Factory Recent Developments
- 6.10 Chengdu Brilliant Pharmaceutical
- 6.10.1 Chengdu Brilliant Pharmaceutical Comapny Information
- 6.10.2 Chengdu Brilliant Pharmaceutical Business Overview
- 6.10.3 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.10.4 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.10.5 Chengdu Brilliant Pharmaceutical Recent Developments
- 6.11 TC Pharmaceuticals (Jiangsu)
- 6.11.1 TC Pharmaceuticals (Jiangsu) Comapny Information
- 6.11.2 TC Pharmaceuticals (Jiangsu) Business Overview
- 6.11.3 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.11.4 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.11.5 TC Pharmaceuticals (Jiangsu) Recent Developments
- 6.12 Sino Therapeutics
- 6.12.1 Sino Therapeutics Comapny Information
- 6.12.2 Sino Therapeutics Business Overview
- 6.12.3 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.12.4 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.12.5 Sino Therapeutics Recent Developments
- 6.13 Kelun Pharmaceutical
- 6.13.1 Kelun Pharmaceutical Comapny Information
- 6.13.2 Kelun Pharmaceutical Business Overview
- 6.13.3 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.13.4 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.13.5 Kelun Pharmaceutical Recent Developments
- 6.14 Qilu Pharmaceutical
- 6.14.1 Qilu Pharmaceutical Comapny Information
- 6.14.2 Qilu Pharmaceutical Business Overview
- 6.14.3 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.14.4 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.14.5 Qilu Pharmaceutical Recent Developments
- 6.15 Shenzhen Salubris Pharmaceuticals
- 6.15.1 Shenzhen Salubris Pharmaceuticals Comapny Information
- 6.15.2 Shenzhen Salubris Pharmaceuticals Business Overview
- 6.15.3 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.15.4 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.15.5 Shenzhen Salubris Pharmaceuticals Recent Developments
- 6.16 CSPC Ouyi Pharmaceutical
- 6.16.1 CSPC Ouyi Pharmaceutical Comapny Information
- 6.16.2 CSPC Ouyi Pharmaceutical Business Overview
- 6.16.3 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.16.4 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.16.5 CSPC Ouyi Pharmaceutical Recent Developments
- 6.17 Sihuan Pharmaceutical
- 6.17.1 Sihuan Pharmaceutical Comapny Information
- 6.17.2 Sihuan Pharmaceutical Business Overview
- 6.17.3 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.17.4 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.17.5 Sihuan Pharmaceutical Recent Developments
- 6.18 Zhejiang AngLiKang Pharmaceutical
- 6.18.1 Zhejiang AngLiKang Pharmaceutical Comapny Information
- 6.18.2 Zhejiang AngLiKang Pharmaceutical Business Overview
- 6.18.3 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.18.4 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.18.5 Zhejiang AngLiKang Pharmaceutical Recent Developments
- 6.19 Zhejiang Nord Pharmaceutical
- 6.19.1 Zhejiang Nord Pharmaceutical Comapny Information
- 6.19.2 Zhejiang Nord Pharmaceutical Business Overview
- 6.19.3 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.19.4 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.19.5 Zhejiang Nord Pharmaceutical Recent Developments
- 6.20 Chia Tai Tianqing Pharmaceutical
- 6.20.1 Chia Tai Tianqing Pharmaceutical Comapny Information
- 6.20.2 Chia Tai Tianqing Pharmaceutical Business Overview
- 6.20.3 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Revenue and Gross Margin (2020-2025)
- 6.20.4 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
- 6.20.5 Chia Tai Tianqing Pharmaceutical Recent Developments
- 7 North America by Country
- 7.1 North America Sacubitril Valsartan Sodium Drugs Sales by Country
- 7.1.1 North America Sacubitril Valsartan Sodium Drugs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.1.2 North America Sacubitril Valsartan Sodium Drugs Sales by Country (2020-2025)
- 7.1.3 North America Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2026-2031)
- 7.2 North America Sacubitril Valsartan Sodium Drugs Market Size by Country
- 7.2.1 North America Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2.2 North America Sacubitril Valsartan Sodium Drugs Market Size by Country (2020-2025)
- 7.2.3 North America Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2026-2031)
- 8 Europe by Country
- 8.1 Europe Sacubitril Valsartan Sodium Drugs Sales by Country
- 8.1.1 Europe Sacubitril Valsartan Sodium Drugs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.1.2 Europe Sacubitril Valsartan Sodium Drugs Sales by Country (2020-2025)
- 8.1.3 Europe Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2026-2031)
- 8.2 Europe Sacubitril Valsartan Sodium Drugs Market Size by Country
- 8.2.1 Europe Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2.2 Europe Sacubitril Valsartan Sodium Drugs Market Size by Country (2020-2025)
- 8.2.3 Europe Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific by Country
- 9.1 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales by Country
- 9.1.1 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.1.2 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales by Country (2020-2025)
- 9.1.3 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2026-2031)
- 9.2 Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size by Country
- 9.2.1 Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2.2 Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size by Country (2020-2025)
- 9.2.3 Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2026-2031)
- 10 South America by Country
- 10.1 South America Sacubitril Valsartan Sodium Drugs Sales by Country
- 10.1.1 South America Sacubitril Valsartan Sodium Drugs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.1.2 South America Sacubitril Valsartan Sodium Drugs Sales by Country (2020-2025)
- 10.1.3 South America Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2026-2031)
- 10.2 South America Sacubitril Valsartan Sodium Drugs Market Size by Country
- 10.2.1 South America Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2.2 South America Sacubitril Valsartan Sodium Drugs Market Size by Country (2020-2025)
- 10.2.3 South America Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2026-2031)
- 11 Middle East and Africa by Country
- 11.1 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Country
- 11.1.1 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.1.2 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales by Country (2020-2025)
- 11.1.3 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Forecast by Country (2026-2031)
- 11.2 Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size by Country
- 11.2.1 Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2.2 Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size by Country (2020-2025)
- 11.2.3 Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size Forecast by Country (2026-2031)
- 12 Value Chain and Sales Channels Analysis
- 12.1 Sacubitril Valsartan Sodium Drugs Value Chain Analysis
- 12.1.1 Sacubitril Valsartan Sodium Drugs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Sacubitril Valsartan Sodium Drugs Production Mode & Process
- 12.2 Sacubitril Valsartan Sodium Drugs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Sacubitril Valsartan Sodium Drugs Distributors
- 12.2.3 Sacubitril Valsartan Sodium Drugs Customers
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.